WO2023157954A1 - サージカルマーキング用インク - Google Patents

サージカルマーキング用インク Download PDF

Info

Publication number
WO2023157954A1
WO2023157954A1 PCT/JP2023/005812 JP2023005812W WO2023157954A1 WO 2023157954 A1 WO2023157954 A1 WO 2023157954A1 JP 2023005812 W JP2023005812 W JP 2023005812W WO 2023157954 A1 WO2023157954 A1 WO 2023157954A1
Authority
WO
WIPO (PCT)
Prior art keywords
ink
water
pen
writing
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2023/005812
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
豊 丸岡
慶 大本
剛 荒殿
俊寿 豊国
森 横山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yasui Co Ltd
Mikuni Color Ltd
Mitsubishi Pencil Co Ltd
National Center for Global Health and Medicine
Original Assignee
Yasui Co Ltd
Mikuni Color Ltd
Mitsubishi Pencil Co Ltd
National Center for Global Health and Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yasui Co Ltd, Mikuni Color Ltd, Mitsubishi Pencil Co Ltd, National Center for Global Health and Medicine filed Critical Yasui Co Ltd
Priority to JP2024501454A priority Critical patent/JP7833135B2/ja
Priority to CN202380022126.6A priority patent/CN118715294A/zh
Publication of WO2023157954A1 publication Critical patent/WO2023157954A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85Polyesters
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D11/00Inks
    • C09D11/16Writing inks
    • C09D11/17Writing inks characterised by colouring agents

Definitions

  • the present invention is suitable for applying surgical markings (surgical markings) to the surface, inner surface, cross-section, etc. of skin epidermis or incised skin tissue, organs, muscles, oral cavity, tongue, bones, etc. in medical practice such as surgery. It relates to a surgical ink (surgical ink) that can be used for
  • a surgical ink As a surgical ink, it has a fixing property that can be fixed on the surface without flowing even on areas covered with oil and moisture such as blood, sweat, and body fluids, and a drying property that dries quickly after fixing and does not cause rubbing or bleeding. , Water resistance that does not easily dissolve or change in body fluids or physiological saline, Color development that realizes the visibility necessary for surgery, ⁇ -ray resistance that does not change even with ⁇ -rays irradiated for disinfection, Biocompatibility, which is composed only of hypoallergenic, non-toxic and safe materials that are adjusted to the optimum pH according to the environment and does not adversely affect the human body, is the main required characteristic.
  • a surgical ink that satisfies as many of these required properties as possible is required, and fixability, color developability, and biocompatibility are particularly important.
  • the coloring can be easily erased and it satisfies erasability that does not leave a mark after surgery. is required.
  • it when it is used as ink for surgical pens, it has excellent jetting properties that can stably eject ink without clogging even in the fine flow paths inside the pen, and the ink does not deteriorate, solidify, separate, or precipitate even after long-term storage. It is also necessary to satisfy long-term stability in which ejection properties are maintained.
  • Patent Documents 1 and 2 use methylrosarinin chloride and methylene blue as coloring materials due to their high color development and ejection properties, but these may be carcinogenic. In recent years, it has been pointed out that it may cause chromosomal abnormalities, etc., and biocompatibility has not been ensured.
  • a surgical ink that does not use methylrosarinin chloride or methylene blue a surgical ink that uses food coloring as a coloring material (Patent Document 3) is disclosed.
  • water resistance is insufficient, and bones, muscles, organs, etc. covered with body fluids such as blood or physiological saline cannot be marked well because they bleed, dissolve, flow, etc., and are not suitable for surgical applications. use is limited to marking non-wetting objects such as skin epidermis and drapes.
  • the ink which is mainly used by injecting it into a target site with a syringe or the like, is assumed to stay in the tissue of the living body and comes into contact with the outside air. It was found that since the ink does not contain a component that forms a film, the fixability, water resistance, and drying properties are insufficient, and the applied ink may easily flow and dissolve. Therefore, it is not suitable for marking places where ink cannot be injected, such as bones and muscles. In addition, the dispersed state and particle size of the coloring material are not adjusted to be suitable for a surgical pen, and there is a risk of ejection failures when used as a pen. In addition, since thin lines and curves cannot be arbitrarily drawn by the method of injecting ink with a syringe, letters, numbers, etc. cannot be written, and its use is limited.
  • inks for foods and the like have biocompatibility, such inks do not meet the required properties as surgical inks and cannot be used favorably.
  • printing inks for edible objects such as food are designed on the assumption that they will be printed on substrates whose surface conditions have been determined in advance by surface treatments such as coating and baking. It is considered that performance such as fixability and color developability cannot be fully exhibited in surgical ink applications where the surface condition is not uniform.
  • the ink which is mainly used for printing on dry substrates, melts and flows due to the blood clinging to the living body and physiological saline for washing, so the marking necessary for surgery is performed. is considered difficult.
  • these edible inks are assumed to be digested in the body, and no consideration is given to erasability, water resistance, and hypoallergenicity on printed materials.
  • Cosmetic ink satisfies biocompatibility and skin irritation on the skin epidermis, but of course it is not taken into account when used on dissected muscles, organs, and bones, and it has an adverse effect on the body. may give
  • it is designed to be extremely water-resistant and fixable on the premise that it will be washed off by rubbing it strongly with soap, etc., but it is not possible to wash the surgical site in such a way, so it is necessary as a surgical ink. It is thought that it does not have a strong erasability.
  • An object of the present invention is to solve the above problems of the prior art. That is, it is an object of the present invention to provide a new ink that is composed only of biocompatible components, satisfies the required properties as a surgical ink, and can be suitably used as an ink for surgical pens.
  • the present inventors have made intensive studies to achieve the above object.
  • the present inventors have found that by adjusting the concentration within the range, it is possible to obtain an excellent ink that is composed only of biocompatible components and that satisfies the required properties required for surgical inks and surgical pen inks, resulting in the present invention. Further, the present inventors have found that by adding a specific basic substance or organic solvent as appropriate, or by adjusting the dispersed particle size, it is possible to obtain an ink exhibiting even better performance as an ink for a surgical pen.
  • the present invention (1) An ink containing at least a coloring material, a dispersion medium, and a water-soluble polymer having a viscosity average molecular weight of 1,000 to 220,000, wherein the coloring material is a carbon material, and the ink has a pH of 4.0. 11.0, the content of the water-soluble polymer is 20 to 200 parts by weight with respect to 100 parts by weight of the coloring material, and the dispersion medium contains water in an amount of 50% by weight or more of the liquid constituting the ink.
  • Surgical ink characterized by (1) The ink according to (1), wherein the carbon material is activated carbon; (3) The ink according to (1) or (2) above, which contains 5% to 30% by weight of a water-soluble organic solvent in the ink liquid; (4) The ink according to (3) above, wherein the water-soluble organic solvent contains one or more of ethanol, isopropanol, polyethylene glycol, propylene glycol and glycerin; (5) The ink according to any one of (1) to (4), wherein the carbon material has an average dispersed particle size of 50 nm to 1 ⁇ m; (6) The ink according to any one of (1) to (5) above, containing 0.01 to 1.00% by weight of at least one of sodium carbonate and sodium hydroxide in the ink liquid; (7) The ink according to any one of (1) to (6), which is an ink for a surgical pen; (8) a cosmetic ink comprising the ink according to any one of (1) to (7); (9) an ink for edibles, comprising the ink
  • the ink of the present invention satisfies important characteristics required as a surgical ink, it is applied to the surface, inner surface, cross section, etc. of a wide range of sites such as skin epidermis or incised skin tissue, organs, muscles, oral cavity, tongue, bones, etc. and can be suitably used for surgical marking in a wide range of operations.
  • it has physical properties suitable for use as a surgical pen ink, so by filling it into a pen and using it, the line width can be adjusted from thin to thick lines, and arbitrary lines, letters, numbers, symbols, etc. can be drawn smoothly and stably. You can write as you like, and you are good at convenience.
  • FIG. 1 is a diagram showing the gingiva on which writing was performed using the pen a in the example.
  • FIG. 2 is a diagram showing the gingiva on which writing was performed using the pen b in the example.
  • FIG. 3 is a diagram showing the gingiva on which writing was performed using the pen c in the example.
  • FIG. 4 is a diagram showing the gingiva on which writing was performed using the pen d in the example.
  • FIG. 5 is a diagram showing the buccal mucosa drawn with the pen a in the example.
  • FIG. 6 is a diagram showing the buccal mucosa drawn with the pen b in the example.
  • FIG. 7 is a diagram showing the buccal mucosa drawn with the pen c in the example.
  • FIG. 8 is a diagram showing buccal mucosa drawn with pen d in Example.
  • FIG. 9 is a diagram showing a tongue on which writing was performed using pen a in the example.
  • FIG. 10 is a drawing showing a tongue on which writing was performed using pen b in the example.
  • FIG. 11 is a diagram showing a tongue on which writing was performed using pen c in the example.
  • FIG. 12 is a diagram showing a tongue on which writing was performed using pen d in the example.
  • FIG. 13 is a diagram showing dry skin on which writing was performed in the example.
  • FIG. 14 is a diagram showing wet skin on which writing was performed in the example.
  • FIG. 15 is a diagram showing the abdominal skin immediately after writing with pen a and pen e in the example.
  • FIG. 16 is a diagram showing the skulls of rats immediately after writing with pen a and pen e in the example.
  • FIG. 17 is a diagram showing the femoral muscles of rats immediately after writing with pen a and pen e in the example.
  • FIG. 18 is a diagram showing the abdominal skin of rats on which writing was performed using pen a and pen e in the example after 7 days.
  • FIG. 19 is a diagram showing the abdominal endothelium of rats after 7 days of writing with Pen a and Pen e in Example.
  • FIG. 20 is a diagram showing the femoral muscles of rats on which writing was performed using pen a in the example after 14 days.
  • the ink of the present invention contains at least a coloring material, a dispersion medium, and a water-soluble polymer, and is characterized by using a carbon material as the coloring material.
  • a carbon material As the carbon material used in the present invention, a wide range of biocompatible materials can be used, and activated carbon, carbon black, graphite, graphite, graphene, fullerene, and the like can be preferably used. These carbon materials have excellent visibility and are biocompatible, in addition to being able to achieve the color development required for surgery. In addition, the inventors' studies have revealed that the use of a carbon material as a coloring material makes it possible to impart ⁇ -ray resistance to the ink.
  • the carbon material dispersed in the ink shields ⁇ -rays and functions to prevent deterioration of other constituents such as water-soluble polymers.
  • This effect is particularly remarkable when the carbon material is activated carbon and the water-soluble polymer is polyvinylpyrrolidone.
  • activated carbon which is particularly excellent in colorability and dispersibility and is available at relatively low cost.
  • one type of these carbon materials can be used alone, or two or more types can be used in combination.
  • Activated carbon is a black porous powder, and its pores are generally used for deodorization, water purification, wastewater treatment, catalyst support, and the like. Particularly purified activated charcoal is taken as medicinal charcoal, and is used to adsorb gas and toxic substances in the intestines and excrete them from the body.
  • activated carbon which is not commonly used as a coloring material, is used as a black coloring material.
  • Activated carbon is known as a carbon material having an extremely large specific surface area. By heating carbon materials such as wood, so-called charcoal such as Bincho charcoal is obtained (this process is called "carbonization"), but the specific surface area of charcoal (including powdered one) is generally It is said to be 300-500 m 2 /g.
  • activated carbon has a specific surface area of 800 to 2000 m 2 /g, and further reaches 500 to 3000 m 2 /g by further treating the charcoal at a high temperature close to 1000°C (such a carbon material).
  • the specific surface area increases and becomes activated carbon by treating it at a high temperature, which is called “activation” or “activation reaction”), and is known to have extremely high adsorption performance.
  • Activated carbon is generally made by reacting carbon materials such as coal and coconut shells with gases and chemicals at high temperatures.
  • a chemical activation method in which a raw material is impregnated with a zinc chloride solution and then heat-activated under certain conditions, and a steam activation method in which a raw material and heated steam are activated at a temperature of 800 to 1000 ° C. are known.
  • the manufacturing method is not particularly limited.
  • Activated carbon can be roughly classified into three types, namely, "coal-based”, “plant-based” and “others”, depending on the raw material, but in the present invention, it can be used without any particular limitation.
  • Powdered activated carbon refers to powder having a particle size that passes through a 100 mesh (0.15 mm mesh) sieve, and granular activated carbon refers to those that do not pass through the sieve.
  • Other special shapes include fibrous activated carbon and specially shaped activated carbon (honeycomb, plate (sheet)). In the present invention, it is preferable to use powdered activated carbon because it is finer and has excellent dispersibility and colorability.
  • the physical properties of the activated carbon used in the present invention are not particularly limited, it generally has an average particle size of 1 to 100 ⁇ m, particularly preferably 5 to 70 ⁇ m.
  • the specific surface area is also not particularly limited, but preferably 500 to 3000 m 2 /g, particularly preferably 1000 to 2000 m 2 /g.
  • the total pore volume is also not particularly limited, but is preferably 0.3-5 ml/g, more preferably 0.5-4 ml/g, and most preferably 0.5-3 ml/g.
  • the average pore diameter is preferably 1-20 nm, particularly preferably 2-10 nm.
  • the pH of the activated carbon is preferably 3-8, particularly preferably 4.5-7.5.
  • the iron content in the activated carbon is preferably 0.03% by weight or less, particularly preferably 0.01% by weight or less. pH, average particle size, specific surface area, total pore volume, average pore diameter, and iron content are measured according to JIS K 1474-91.
  • the activated carbon used in the present invention contains 0.53% or less chloride (as Cl) and 0.5% sulfate (as SO 4 ) in accordance with JIS K 1474-91 and the method described in the Official Code of Food Additives. 48% or less, 0.10% or less zinc, and 4.0 ⁇ g/g or less arsenic (as As2O3) are preferred. These ranges meet food additive standards and are not toxic to the human body, and can prevent impurities from affecting physical properties of the ink.
  • the blending amount of activated carbon in the ink liquid is desirably 0.1% to 10% by weight, preferably 0.5% to 8% by weight, more preferably 1% to 5% by weight. If it is less than 0.1% by weight, the concentration as a coloring agent is low, and the ink may not have sufficient color developability. If it exceeds 10% by weight, it may become difficult to perform stable writing due to deterioration in stability over time due to aggregation of activated carbon, and deterioration in ejection properties from a marking pen.
  • Water-soluble polymer The present invention is characterized by containing a water-soluble polymer having a viscosity average molecular weight of 1,000 to 220,000.
  • a compound called a dispersant is added to prepare a liquid composition in which solid fine particles such as pigment are dispersed in a liquid medium.
  • solid fine particles such as pigment are dispersed in a liquid medium.
  • surfactants with relatively low molecular weights and polymer compounds with higher molecular weights. broadly classified.
  • polymer compounds generally have many hydrophilic groups in the molecular chain, and water molecules are hydrated and dissolved, and there are long-chain aminoamides, acrylic acid / polycarboxylic acid and their salts, etc.
  • As the main structure there are basic ones such as amides and amines as adsorptive groups that adsorb to solid fine particles, and soluble types as neutralized salts having acidic groups such as carboxyl groups and phosphoric acid groups.
  • the viscosity average molecular weight of the water-soluble polymer is 1,000 to 220,000, preferably 2,000 to 100,000, more preferably 5,000 to 100,000, most preferably 7,000 to 50,000. be. If the viscosity-average molecular weight is less than 1,000, the ink will not form a film during writing and cannot be fixed on the writing object. If the viscosity-average molecular weight exceeds 220.000, the fixation to the object to be written becomes strong, and the erasability required as a surgical ink cannot be obtained. Measurement of the viscosity average molecular weight is basically carried out according to Kobunshi Ronbunshu vol. 38, No. 7, pp. 457-463 (July, 1981) for molecular weight determination. That is, the procedure is as follows.
  • the numerical value of the molecular weight may fluctuate by about 10% due to measurement errors. Therefore, it does not matter if the range is about 10% above or below the numerical range described above.
  • the water-soluble polymer used in the present invention is particularly preferably nonionic.
  • an acid value As an indicator of polarity, there is an acid value.
  • the acid value is preferably 30 mgKOH/g or less, more preferably 20 mgKOH/g or less, still more preferably 5 mgKOH/g or less, and most preferably no acid value is detected (acid value is substantially 0 mg KOH/g). Within this range, the dispersibility of the carbon material and the water resistance of the ink are particularly excellent.
  • the acid value is measured according to DIN53402, more specifically as follows. (1) A sample of 0.9 to 1.3 g is placed in a beaker and weighed. (2) Add 50 ml of acetone. (3) Measure with an automatic potentiometric titrator using 0.1N NaOH aqueous solution. The results are the same regardless of which automatic potentiometric titrator is used. (4) The amine value is determined by the following formula.
  • water-soluble polymers include casein, water-soluble cellulose derivatives, polyvinylpyrrolidone, acrylic polymers having an acid value such as styrene acrylic, and water-soluble polymers having a carboxylic acid group. It can be selected as appropriate according to the writing material.
  • a cellulose ether substituted with an alkyl group and a hydroxyalkyl group, or a cellulose ether substituted with a hydroxyalkyl group is preferably used as the water-soluble cellulose derivative.
  • nonpolar water-soluble polymers such as hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC), and polyvinylpyrrolidone.
  • HPC hydroxypropylcellulose
  • HPMC hydroxypropylmethylcellulose
  • polyvinylpyrrolidone polyvinylpyrrolidone
  • water-soluble polymers have good adhesion to the skin epidermis, incised subcutaneous tissue, organ surfaces, muscles, bones, oral cavity, tongue, etc., and can be suitably used.
  • polyvinylpyrrolidone is most preferable because it has particularly excellent fixability, is widely recognized for its biocompatibility as a food additive, exhibits resistance to ⁇ -rays by interacting with activated carbon, and has high dispersibility. .
  • the water-soluble polymer is added in an amount of 20 to 200 parts by weight per 100 parts by weight of the carbon material. More preferably 25 to 180 parts by weight, most preferably 30 to 150 parts by weight. If it is less than 20% by weight, it is difficult to sufficiently disperse the coloring material, and the dispersed particle size of the carbon material in the dispersion medium becomes large. It may be the cause. If the amount exceeds 200 parts by weight, the viscosity of the ink increases, making it difficult to eject the ink from the pen core, resulting in poor writing performance.
  • the ink of the present invention can stably and finely disperse the carbon material by blending the specific water-soluble polymer described above, and can be suitably used as a surgical ink.
  • the carbon material has excellent color tone expression, improved adhesion when writing on the surgical site, good adhesion to the writing target, and friction during surgery. Excellent black writing that does not disappear and can be erased by wiping with a wet gauze or the like is now possible.
  • the mechanism by which such an excellent effect is obtained is not completely clear, it has a good affinity with the carbon material, which is a porous fine powder, and interacts with the polarity of the particle surface of the carbon material. It is presumed that the prevention of agglomeration and the stabilization of the particle state contribute to the effect.
  • the present invention is characterized in that the dispersion medium is mainly water.
  • the ink can be made excellent in terms of biocompatibility, safety, and operability.
  • the dispersion state is stable even when water is mainly used as the dispersion medium, and the ejection property in writing with a surgical pen can be stably maintained.
  • water used in the present invention is not particularly limited, distilled water or water for injection that is appropriately quality-controlled for medical use is suitable.
  • water is the main component means that water accounts for 50% by weight or more, more preferably 60% by weight or more, of the liquid constituting the ink.
  • the liquid constituting the ink 50% by weight or more of the liquid constituting the ink is water.
  • the liquid component other than the specific water-soluble organic solvent described below is substantially water.
  • the liquid is not particularly limited as long as it can disperse the carbon material, and the liquid may be appropriately selected depending on the application.
  • Water-soluble organic solvent In the present invention, it is desirable to contain a specific water-soluble organic solvent as a liquid component other than water.
  • the addition of these water-soluble organic solvents has the effect of preventing clogging of the pen core when writing with a surgical pen, especially a marker pen type surgical pen, and also adjusts the ink drying property according to the pen structure. can do.
  • Specific examples of such water-soluble organic solvents include methanol, ethanol, n-propanol, iso-propanol, n-butanol, iso-butanol, t-butanol, trimethylolpropane, ethylene glycol monoethyl ether, and ethylene.
  • Glycol monobutyl ether monoethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, propylene glycol, butylene glycol, 1,2,6-hexanetriol, thioglycol, hexylene glycol, glycerin, diglycerin, 1,2-hexane Diol, 1,6-hexanediol, 2-pyrrolidone, N-methyl-2-pyrrolidone, 1,5-pentanediol, monoethylene glycol monomethyl ether, monoethylene glycol monoethyl ether, monoethylene glycol monobutyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol dimethyl ether, diethylene glycol monobutyl ether, triethylene glycol monoethyl ether, triethylene glycol dimethyl ether, triethylene glycol monobutyl ether, methyl lactate, ethyl lactate, 1,3-dimethyl-2-
  • the amount of the water-soluble organic solvent added is preferably 5% to 35% by weight in the ink liquid in the embodiment of the present invention. More preferably 10% to 30% by weight. Addition of more than 35% by weight may increase the viscosity of the ink, lower the stability and ejection properties of the ink, and slow the drying speed. Addition of less than 5% by weight may result in unstable ejection from the pen core when used as a surgical pen, which may result in blurring or clogging, resulting in deterioration in writability.
  • a surface tension modifier can be used as necessary.
  • the surface tension adjuster is a component that functions to improve the ejection property from the pen core and to adjust the surface tension.
  • Specific examples of surface tension modifiers include nonionic and anionic surfactants.
  • alkylbenzenesulfonates such as naphthalene sulfonates, alkyl sulfosuccinates, naphthalene sulfonic acid formalin condensate salts, polyoxyethylene alkyl ether sulfates, polyoxyethylene alkyl phosphates;
  • Nonionic surfactants such as ethylene alkylphenyl ether, fatty acid monoglyceride, sorbitan fatty acid ester, sucrose fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene fatty acid ester, glycerin fatty acid ester, polyoxyethylene-added acetylene glycol, silicone type Surfactants, fluorosurfactants, water-soluble organic solvents such as ethanol and isopropanol can be mentioned.
  • the amount of the surface tension modifier to be added may be appropriately selected according to the
  • a basic substance can be present in the ink in order to adjust the pH within a predetermined range.
  • the ink tends to exhibit acidity due to the carbonaceous material. Therefore, if neutralization with a basic substance is not carried out, depending on the site, the ink may be strongly irritating to the living body.
  • the suitable pH range differs depending on the part of the living body, in the present invention, by appropriately adjusting the amount of the basic substance added, the pH can be adjusted to the appropriate range according to the marking part, and the irritation can be reduced. can be done.
  • the basic substance of the present invention is not particularly limited as long as it is biocompatible among substances exhibiting basicity according to the definition of Arrhenius. pH adjusters such as sodium carbonate, sodium hydroxide, potassium carbonate and sodium hydrogen carbonate are preferred. Among these, sodium carbonate and sodium hydroxide are particularly preferred, and sodium hydroxide is most preferred.
  • sodium hydroxide is most suitable for use as an ink for surgical pens.
  • the dispersed state of particles in the ink is stabilized even for difficult-to-disperse pigments such as activated carbon. It is possible to prevent solidification, grain increase, viscosity increase, and the like.
  • the mechanism by which sodium hydroxide contributes to the stabilization of the dispersed state is not clear, it is believed that the effect of stabilizing the surface activity of the carbon material particles and preventing aggregation is exhibited.
  • the basic substance is preferably contained in an amount of 0.01 to 1.00 parts by weight, more preferably 0.05 to 0.50 parts by weight, based on 100 parts by weight of the ink. If the amount of the basic substance is less than 0.01 part by weight, the change in pH is insufficient, and when sodium hydroxide is used, the effect of stabilizing the dispersed state cannot be fully exhibited. If the amount added is more than 1.00 parts by weight, the pH may become higher than the appropriate range for living organisms, resulting in strong irritation.
  • a water-soluble polymer and other components may be added as appropriate within a range that does not interfere with the performance of the present invention.
  • starches such as guar gum, locust bean gum, agar, and methyl starch
  • non-polar water-soluble polymers such as gelatin, pullulan, xanthan gum, tragacanth gum, dextrin, casein, water-soluble cellulose derivatives, polyvinyl alcohol, and polyvinylpyrrolidone are added.
  • the ink of the present invention is characterized by containing a carbon material as a coloring material, but other coloring materials may be contained within a range that does not interfere with the performance of the present invention.
  • the carbon material in the ink of the present invention has an average dispersed particle size of 50 nm to 1 ⁇ m, preferably 50 to 800 nm, more preferably 50 to 700 nm, even more preferably 50 to 600 nm, still more preferably 50 to 500 nm, still more preferably 100 nm. ⁇ 450 nm, most preferably between 150 and 400 nm.
  • the coloring strength, dispersion stability, fixability, and ejection properties are excellent. Performance is particularly good. If the average dispersed particle size is less than 50 nm, van der Waals forces between the particles tend to cause agglomeration, which tends to lower the stability over time. When the average dispersed particle size exceeds 1 ⁇ m, the coloring material in the liquid tends to separate and precipitate.
  • the average dispersed particle size it is preferable not only to control the average dispersed particle size, but also to suppress the amount of coarse particles. Specifically, if 90% or more of all the carbon material particles in the liquid are adjusted so that the dispersed particle diameter is 1 ⁇ m or less, more preferably 500 nm or less, an ink with even better physical properties can be obtained. As a method of adjustment, it is conceivable to perform dispersion treatment until 90% or more of all carbon material particles have a dispersed particle diameter of 1 ⁇ m or less, more preferably 500 nm or less.
  • the methods for measuring the average dispersed particle size and the dispersed particle size of all particles in the present invention are as follows, but are not limited thereto as long as similar results can be obtained.
  • Conditioning Dilute the undiluted solution with deionized water so that it falls within the measurement concentration range specified for each measuring instrument.
  • Measuring instrument Dynamic Light Scattering Particle Size Distribution Analyzer (NIKKISO: Microlracwave-EX150) Measurement time: 120 seconds
  • the viscosity of the ink of the present invention is preferably 1.0 to 10.0 mPa ⁇ s. More preferably, it is 1.5 to 9.0 mPa ⁇ s, and most preferably 2.0 to 8.0 mPa ⁇ s. If the viscosity is less than 1.0 mPa ⁇ s, too much ink may come out from the pen core when used as a surgical pen. Conversely, if the viscosity exceeds 10.0 mPa ⁇ s, the ink will be difficult to come out of the pen core, causing blurring.
  • the method for measuring viscosity in the present invention is as follows, but is not limited to this method as long as similar results can be obtained.
  • the ink of the present invention is characterized by having a pH value of 4.0 to 11.0. If it is out of this range, it cannot be used as a surgical ink because it is highly irritating to the living body. Although a pH of 6.0 to 9.0 is more preferable in many parts of the body, irritation can be reduced by adjusting the pH to an appropriate value according to the part to be applied.
  • the method for measuring pH is not particularly limited, it can be carried out as follows. Conditioning: Undiluted solution Measurement equipment: pH measuring instrument ("MH-41X type" manufactured by Toa DKK Co., Ltd.) Measurement temperature: 25°C
  • the ink of the present invention can be gamma ray resistant. That is, as will be shown in Examples to be described later, the ink of the present invention has almost no change in physical properties before and after ⁇ -ray irradiation and maintains stable quality for a long period of time even after ⁇ -ray irradiation.
  • the average dispersed particle size, viscosity and pH can be maintained within the above preferred ranges, and the average dispersed particle size, viscosity and pH can be maintained within the most preferred ranges.
  • the carbon material shields gamma rays by containing the carbon material and functions to prevent deterioration of other constituents such as water-soluble polymers.
  • the present inventors' studies have also revealed that this is particularly remarkable when the material is activated carbon and the water-soluble polymer is polyvinylpyrrolidone, and this is also supported by the examples described later.
  • the ink does not deteriorate even when irradiated with ⁇ -rays for sterilization of surgical pens, and physical properties suitable for surgical ink can be maintained, causing problems such as ejection failure. Marking and writing can be done without
  • the absorbed dose of 25 kGy to 70 kGy is a dose that ensures sterility in common for the surgical ink according to the present invention and the surgical pen using it, and sterilization validation (JIS T 0806-1 / ISO 11137-1 and JIS T 0806-2 / ISO 11137-2), (1) material test, (2) bioburden measurement, (3) sterilization dose setting test, (4) sterility test, (5) dose It was determined through distribution evaluation.
  • Bioburden measurement and (4) Sterility test are respectively JIS / ISO standard "Method for measuring microorganisms on products" (JIS T 11737-1 / ISO 11737-1) and "Definition of sterilization process, validation and sterility test performed in maintenance” (JIS T 11737-2/ISO 11737-2). That is, the sterility assurance level (SAL) is set to 10-6, and the number of living microorganisms per unit of irradiation obtained from (1) bioburden measurement and (4) sterility test and its From the lethal rate (the time required to reduce the number of bacteria to one-tenth: D value), the absorbed dose of ⁇ -rays at which the SAL is achieved is determined.
  • SAL sterility assurance level
  • the gamma-ray irradiation time for ensuring sterility is longer than the time (approximately 2 to 3 hours) required to achieve the absorbed dose of gamma rays that achieves the SAL.
  • the absorbed dose is 25 kGy to 70 kGy, more preferably 25 kGy to 45 kGy. If the absorbed dose is less than 25 kGy, sterility cannot be ensured, and if it is greater than 70 kGy, radiation deterioration may be accelerated and the properties of the ink may be changed inadvertently.
  • the absorbed dose range of 25 kGy to 70 kGy is an error that can be made according to the relative distance between the position where each object to be sterilized is stored and arranged in the tote box and the radiation source, and the surgical ink filled with the surgical ink of the present invention.
  • the sterility is guaranteed in the sterility test, and (1) the mechanical strength in the material test is guaranteed.
  • the ink of the present invention is preferably subjected to ⁇ -ray irradiation treatment after preparation of the ink. Specifically, after preparing the ink, ⁇ -ray irradiation is performed at an absorption dose of 25 kGy to 70 kGy in accordance with JIS/ISO standards (JIS T 0806-1/ISO 11137-1 and JIS T 0806-2/ISO 11137-2). Treatment is preferred, and an absorbed dose of 25 kGy to 45 kGy is more preferred.
  • JIS/ISO standards JIS T 0806-1/ISO 11137-1 and JIS T 0806-2/ISO 11137-2
  • Treatment is preferred, and an absorbed dose of 25 kGy to 45 kGy is more preferred.
  • ⁇ -ray irradiation treatment Radionuclide: Co60
  • Irradiation facility Japan Irradiation Service Co., Ltd.
  • Tokai Center Irradiation container Tote box (78 x 50 x 150 cm)
  • Irradiation device (model) JS10000HD, IR-199, (manufacturer) MDS Nordion Set target absorbed dose: 50 kGy (Actual value 54.0 kGy to 67.6 kGy)
  • Irradiation time 26,000 seconds
  • the ink of the present invention can be such that its physical properties do not deteriorate even after long-term storage.
  • the average dispersed particle size, viscosity, and pH are preferably within the above preferred ranges after 30 days or more from production, and more preferably after 60 days or more, these are within the above preferred ranges. Most preferably, they can be within the above preferred range even after 90 days or more. Since the above physical properties can be maintained within a preferable range even during long-term storage, stable writing can be performed without impairing dischargeability, writing comfort, and hypoallergenicity even when stored in a pen. can.
  • the method for producing the ink of the present invention is not particularly limited, and the ink may be prepared by mixing the respective components described above.
  • a carbon material, a water-soluble polymer, and water are mixed and stirred, and then dispersed using a commercially available dispersing machine such as a paint shaker, roll mill, ball mill, sand mill, jet mill, etc. It can be produced by appropriately adding various additives such as a water-soluble organic solvent and a surface tension modifier to form an ink.
  • the quality of the ink can be further improved by subjecting the ink prepared as described above to filtering, magnetic separation, removal of impurity ions, and the like by known methods.
  • adding a step of removing coarse particles after mixing and stirring the carbon material, the water-soluble polymer, and water in the above production method can also produce an ink that maintains a stable and good dispersion state.
  • the method and timing are not particularly limited.
  • it can be added together with water, a carbon material, and a water-soluble polymer when they are mixed and stirred, or can be added together with additives such as a water-soluble organic solvent and a surface tension modifier after dispersion treatment.
  • the gamma ray irradiation treatment is performed, it is performed after the ink is prepared as described above.
  • the ink may be placed in a ⁇ -ray-resistant container such as a plastic container and then subjected to ⁇ -ray irradiation, or may be filled in an arbitrary pen and used as a surgical pen before performing the ⁇ -ray irradiation.
  • a ⁇ -ray-resistant container such as a plastic container and then subjected to ⁇ -ray irradiation
  • ⁇ -ray irradiation or may be filled in an arbitrary pen and used as a surgical pen before performing the ⁇ -ray irradiation.
  • the ink of the present invention described above can be applied and written on various objects.
  • surgical marking can be performed by attaching the ink of the present invention to the tip of a bamboo skewer, a cotton swab, a writing brush, a spatula, or the like and applying the ink to the desired marking.
  • by filling a surgical pen and writing it is possible to perform more precise marking by adjusting the line width and dot size.
  • writing instruments such as markers, felt-tip pens, and plastic pens that have been used as stationery can be used after disinfection.
  • marker pen type pens have particularly fine ink channels, and ink using pigments tends to have problems with writing properties such as ejection properties, but in the present invention, physical properties suitable for writing are achieved by combining the above components is expressed, it can be preferably used.
  • the ink of the present invention is biocompatible and consists only of components that can be safely ingested into the body, it can be used in applications that require biocompatibility other than surgical inks, such as cosmetics, sanitary products, foods, toys, It can also be suitably used for writing, decorating, printing, etc. on infant products, pharmaceuticals, and the like.
  • it because of its excellent colorability and fixing properties, it can be used for various purposes such as counterfeit prevention, traceability recording, display of precautions such as accidental ingestion prevention, improvement of distinguishability, design and amusement. can be used for the purpose.
  • Example 1 Preparation of Dispersion The components shown below were blended and stirred at room temperature for 1 hour using a propeller stirrer.
  • Ingredient Amount (parts by weight (hereinafter referred to as “parts”))
  • Activated carbon 10.0 (Average particle size: 35 ⁇ m, average pore diameter: 3.4 nm)
  • polyvinylpyrrolidone 7.22 (Viscosity average molecular weight: 50,000) water 82.78
  • (C) Fixability/drying test Fill the marker pen used in the above (B) writing test with ink, write on the dry skin of the back of the hand, rub the writing part three times with a dry nonwoven fabric, and spread the ink. The presence or absence of ink transfer to the nonwoven fabric was investigated. In Table 1, ⁇ indicates that the ink did not spread and was not transferred to the nonwoven fabric, and x indicates that any one of these conditions was not satisfied.
  • (D) Water resistance test Fill the marker pen used in the above (B) writing test with ink, write on the dry skin of the back of the hand, and after 10 minutes, flush the writing part with running tap water for 1 minute and write. The visibility of drawn lines and the presence or absence of bleeding were investigated. In Table 1, ⁇ indicates that the drawn line was clearly visible and neither bleeding nor spread to the periphery was confirmed, and x indicates that any one of these conditions was not satisfied.
  • Example 2 An ink was prepared in the same manner as in Example 1, except that the composition at the time of ink formation was changed to the following.
  • Ingredient Amount (parts) Dispersion 1 (10% solids) 68.03 Propylene glycol 5.0 Ethanol 15.0 water 11.97
  • the obtained ink had an average dispersed particle size of 313 nm, a viscosity of 4.3 mPa ⁇ s, and a pH of 4.9.
  • the obtained ink exhibited a uniform black color in appearance.
  • the above ink was evaluated in the same manner as in Example 1. Table 1 shows the results.
  • Example 3 An ink was prepared in the same manner as in Example 1, except that the composition at the time of ink formation was changed to the following.
  • Ingredient Amount (parts) Dispersion 1 (10% solids) 75.83 Propylene glycol 5.0 Sodium carbonate 0.0064 Water 19.16
  • the obtained ink had an average dispersed particle size of 352 nm, a viscosity of 2.8 mPa ⁇ s, and a pH of 6.1.
  • the obtained ink exhibited a uniform black color in appearance.
  • the above ink was evaluated in the same manner as in Example 1. Table 1 shows the results.
  • Example 4 An ink was prepared in the same manner as in Example 1, except that the composition at the time of ink formation was changed to the following.
  • the obtained ink had an average dispersed particle size of 300 nm, a viscosity of 5.1 mPa ⁇ s, and a pH of 6.2.
  • the obtained ink exhibited a uniform black color in appearance.
  • Table 1 shows the results.
  • Example 5 In Example 1, a dispersion was prepared in the same manner as in Example 1 except that the formulation of the dispersion was as follows. The resulting dispersion was designated as "dispersion 2".
  • Ingredient Amount Activated carbon 9.0 Average particle size: 35 ⁇ m, average pore diameter: 3.4 nm
  • polyvinylpyrrolidone 6.3 Viscosity average molecular weight: 25,000
  • Example 2 An ink was prepared in the same manner as in Example 1, except that the resulting dispersion liquid 2 was used in the formulation of the ink as follows. Ingredient Amount (parts) Dispersion 2 (10% solids) 62.5 Propylene glycol 25.0 water 12.5 The resulting ink had an average dispersed particle size of 290 nm, a viscosity of 6.1 mPa ⁇ s, and a pH of 8.9. In addition, the obtained ink exhibited a uniform black color in appearance. Furthermore, the above ink was evaluated in the same manner as in Example 1. Table 1 shows the results.
  • Example 6 An ink was prepared in the same manner as in Example 5, except that the composition of the ink was changed to the following. Ingredient Amount (parts) Dispersion 2 (10% solids) 62.5 Propylene glycol 20.0 Ethanol 5.0 water 12.5 The resulting ink had an average dispersed particle size of 270 nm, a viscosity of 5.7 mPa ⁇ s, and a pH of 8.7. In addition, the obtained ink exhibited a uniform black color in appearance. Furthermore, the above ink was evaluated in the same manner as in Example 1. Table 1 shows the results.
  • Example 8 In Example 1, a dispersion was prepared in the same manner as in Example 1 except that the formulation of the dispersion was as follows. The resulting dispersion was designated as "dispersion 3". Ingredient Amount Activated carbon 9.0 (Average particle size: 35 ⁇ m, average pore diameter: 3.4 nm) polyvinylpyrrolidone 6.3 (Viscosity average molecular weight: 40,000) sodium hydroxide 0.129 water 84.571
  • Dispersion Liquid 3 thus obtained, an ink was prepared in the same manner as in Example 1, except that the formulation at the time of making the ink was changed to the following.
  • Propylene glycol 25.0 water 12.5 The resulting ink had an average dispersed particle size of 346 nm, a viscosity of 7.7 mPa ⁇ s, and a pH of 9.2.
  • the obtained ink exhibited a uniform black color in appearance.
  • the above ink was evaluated in the same manner as in Example 1. Table 1 shows the results.
  • Example 9 An ink was prepared in the same manner as in Example 5, except that the composition of the ink was changed to the following.
  • the resulting ink had an average dispersed particle diameter of 307 nm, a viscosity of 7.6 mPa ⁇ s, and a pH of 8.0.
  • the obtained ink exhibited a uniform black color in appearance.
  • Table 1 shows the results.
  • Comparative Example 2 An ink was prepared in the same manner as in Comparative Example 1 except that black iron oxide was used instead of red iron oxide.
  • the resulting ink had an average dispersed particle size of 1130 nm, a viscosity of 5.4 mPa ⁇ s and a pH of 9.1.
  • the obtained ink exhibited a uniform black color in appearance. Further, the above ink was tested and evaluated in the same manner as in Example 1. Table 1 shows the results.
  • Comparative Example 3 An ink was prepared in the same manner as in Comparative Example 1, except that red iron oxide was used as the water-soluble black dye. The resulting ink had a viscosity of 4.2 mPa ⁇ s and a pH of 7.1. In addition, the obtained ink exhibited a uniform black color in appearance. Further, the above ink was tested and evaluated in the same manner as in Example 1. Table 1 shows the results.
  • Example 7 A performance evaluation test was conducted when writing on the human body by the following methods (A) and (B) using a pen filled with the following: The ink obtained in Example 5 was filled into a padding type marker pen using a fiber bundle core (diameter 12 mm) made of a polyurethane resin-bound PET resin fiber bundle with a substantially hemispherical tip as the pen tip, and the "pen a”.
  • Example 5 was filled in a marker pen similar to pen a, except that the diameter of the fiber bundle core was 9 mm, to obtain "pen b".
  • a pen similar to pen a except that the ink obtained in Example 7 was filled instead of the ink obtained in Example 5 was designated as "pen c", and the ink obtained in Example 5 was used.
  • a pen similar to pen b except that it was filled with the ink obtained in Example 7 was referred to as "pen d".
  • FIGS. 13 and 14 Results of Writing Test on Skin Surface
  • FIGS. 13 and 14 FIG.
  • the straight line with the number "107-12” written on the right is pen a
  • the straight line with "107-9” is pen b
  • the straight line with "109-12” is pen c
  • "109-9" is drawn by pen d.
  • the numbers in FIG. 13 were written using the corresponding pens.
  • the straight line drawn on the left side of the number is the straight line drawn on the wet skin. In writing with any of the pens, the following good results were obtained in both writing (1) and (2).
  • ⁇ Writability and dischargeability In both straight line writing and number writing, there was no difficulty in writing such as ink discharge failure or clogging, and writing was possible without slipping. • Fixability: Even when wet, the ink was fixed and remained on the writing site without flowing. ⁇ Color developability: The written portion was clearly visible. ⁇ Water resistance and dryness: Even with running water, there was no bleeding or blurring, and the written area was clearly visible. • Erasability: The ink was erased without bleeding or spreading, and there was no pigmentation or the like, leaving no marks.
  • Tokai Center Irradiation container Tote box (78 x 50 x 150 cm)
  • Irradiation device (model) JS10000HD, IR-199, (manufacturer) MDS Nordion Set target absorbed dose: 50 kGy (Actual value 54.0 kGy to 67.6 kGy)
  • Irradiation time 26,000 seconds
  • ⁇ Writing area Abdominal skin, skull, thigh muscle, tongue, buccal mucosa
  • ⁇ Writing method The abdominal skin was shaved under general anesthesia, and an ellipse about 1 cm wide and 2 cm long was drawn on the outer skin.
  • a dot-like tattoo was applied around the writing area using a blue pigment dispersion ("SA Blue 5636" manufactured by Mikuni Shiyo Co., Ltd.).
  • SA Blue 5636 manufactured by Mikuni Shiyo Co., Ltd.
  • each part of the skull and thigh muscles is incised, and an oval with a width of 1 cm and a length of about 2 cm is drawn on each part using a marker pen in the same way as for the abdominal skin. was applied and sutured.
  • the tongue and buccal mucosa were opened under general anesthesia, and circles and dots with a diameter of about 5 mm were tattooed.
  • a surgical pen filled with a 0.2% aqueous solution of methylrosarinin chloride (manufactured by Honzo Pharmaceutical Co., Ltd., "Honzo") as ink (manufactured by Mizuho Co., Ltd., "Tajima-style mark pen (skin pen)", (hereinafter referred to as "pen e")) was used to write, and the color development properties were compared.
  • pen e methylrosarinin chloride
  • FIGS. 15-20 The respective writing units are shown in FIGS. 15-20.
  • the lower part is the part written with the pen a
  • the upper part is the part written with the pen e
  • the points around each are the position confirmation tattoos using the blue pigment dispersion liquid.
  • the lower ellipse in the drawing is the writing area with the pen a
  • the upper ellipse is the writing area with the pen e.
  • the left side of the figure is the thigh muscle drawn with the pen a
  • the right side is the thigh muscle drawn with the pen e.
  • FIG. 18 as well, the same portions as in FIG.
  • the ink before and after the ⁇ -ray treatment was stored in a constant temperature room at 25°C and 50°C, respectively, for 30 days, 60 days, and 90 days.
  • the average dispersed particle size, viscosity and pH were measured after the lapse of days.
  • the results are shown in Table 2.
  • the "rate of change" means that the physical property value before storage (at the time of 0 days) under each condition before irradiation and after irradiation is 100%, and the decrease from that value is -%, and the increase is +. %.
  • the ink obtained in Example 5 was subjected to a writing test over time by the following method. First, the ink obtained in Example 5 was filled in the same marker pen as that used in the above (b) writing test to prepare a pen. Multiple pens were made and divided into 6 groups, A, B, C, D, E, and F. The pens of groups A, B, and C were placed in a temperature-controlled room at 25°C, and the pens of groups D, E, and F were placed in a temperature-controlled room at 50°C.
  • Groups A and D Upward (point the pen tip to the sky and place the pen perpendicular to the horizontal surface)
  • Groups B and E Downward (with the pen tip facing the ground and the pen standing perpendicular to the horizontal surface)
  • Groups C and F Sideways (Stand so that the pen is horizontal)
  • Example 8 and Example 9 were also subjected to a writing test over time. As for Example 9, confirmation was not performed after 90 days had passed after standing. Each result is shown in Table 3.
  • the ink of the present invention which uses a carbon material as a coloring material and contains a predetermined water-soluble polymer, has excellent properties as a surgical ink. I know there is.
  • the comparison of physical properties before and after ⁇ -ray irradiation shown in Table 2 shows that the ink of the present invention maintains physical properties suitable as a surgical ink even after ⁇ -ray irradiation treatment. was done. Also, from the results of the evaluation over time shown in Table 2, the average dispersed particle diameter, It was confirmed that the viscosity and pH values were all within the above most preferred ranges. It was also confirmed that the average dispersed particle size, viscosity and pH after 90 days of storage at 50°C were all within the preferred ranges described above.
  • the ink of Example 6-2 regardless of the presence or absence of ⁇ -ray irradiation treatment, the average dispersed particle size, viscosity, and pH values were all the above-mentioned most preferable values even after 90 days of storage at 25°C and 50°C. Confirmed to be within range. Therefore, it was shown that the ink of the present invention can be suitably used as a surgical ink even when it is filled in a pen and stored for a long period of time.
  • the ink of the present invention was stored at 25°C even when it was filled in a pen and stored for a long period of time. It was shown that good writability can be maintained in any direction.
  • the inks of Examples 8 and 9, which had higher viscosities than those of Example 5, were practically usable for a long period of time even when stored at 50°C in a downward orientation in which writing performance tends to deteriorate. It was shown that sufficient writability can be maintained.
  • Example 1 The evaluation results shown in Table 1 for the inks obtained in Examples 1, 2, 3, 4, 6, 8, and 9 were the same as those in Example 5, and the writability and fixability of the inks were significantly affected. Similar to Example 5, which contains activated carbon and polyvinylpyrrolidone, which are assumed to contribute greatly to the performance of the ink. composition. Therefore, the inks obtained in Examples 1, 2, 3, 4, 8 and 9 were also subjected to performance evaluation tests on human epidermis and rats, physical property measurement before and after ⁇ -ray irradiation, and evaluation tests over time. Good results similar to those of the ink obtained in Example 5-2 are obtained, and it is naturally foreseen that the ink will be suitably used for surgical applications. Similarly, the ink obtained in Example 6 also gave good results similar to those of the ink obtained in Example 5 in performance evaluation tests on human epidermis and rats, indicating that it is suitable for surgical applications. is naturally foreseen.
  • an excellent ink that satisfies the required properties as a surgical ink only with components that can be taken into the body and can be suitably used in writing with a surgical pen, a writing method using the same, and a surgical marker A method for producing ink can be provided.
  • the ink of the present invention can be suitably used for writing, decorating, printing, etc. on cosmetics, sanitary products, foods, toys, daily necessities for infants, pharmaceuticals, etc., and can be used for various purposes.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
PCT/JP2023/005812 2022-02-18 2023-02-17 サージカルマーキング用インク Ceased WO2023157954A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024501454A JP7833135B2 (ja) 2022-02-18 2023-02-17 サージカルマーキング用インク
CN202380022126.6A CN118715294A (zh) 2022-02-18 2023-02-17 手术标记用墨液

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022-023688 2022-02-18
JP2022023688 2022-02-18

Publications (1)

Publication Number Publication Date
WO2023157954A1 true WO2023157954A1 (ja) 2023-08-24

Family

ID=87578716

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2023/005812 Ceased WO2023157954A1 (ja) 2022-02-18 2023-02-17 サージカルマーキング用インク

Country Status (4)

Country Link
JP (1) JP7833135B2 (https=)
CN (1) CN118715294A (https=)
TW (1) TW202348748A (https=)
WO (1) WO2023157954A1 (https=)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012126820A (ja) * 2010-12-15 2012-07-05 Sakura Color Products Corp 固形マーキングペン
US20140182480A1 (en) * 2011-10-20 2014-07-03 Endochoice Inc. Ink Formulation and Manufacture Thereof
JP2016084417A (ja) * 2014-10-27 2016-05-19 紀州技研工業株式会社 インクジェットインク及びその印字方法
JP2019014912A (ja) * 2015-01-21 2019-01-31 クオリカプス株式会社 インク及びこれを用いた可食体の製造方法並びに可食体の印刷方法
JP2021187901A (ja) * 2020-05-27 2021-12-13 紀州技研工業株式会社 錠剤用インクジェットインク
KR102350083B1 (ko) * 2020-07-10 2022-01-10 이상주 레이저 시술용 마커 조성물 및 이를 이용한 레이저 조사방법

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012126820A (ja) * 2010-12-15 2012-07-05 Sakura Color Products Corp 固形マーキングペン
US20140182480A1 (en) * 2011-10-20 2014-07-03 Endochoice Inc. Ink Formulation and Manufacture Thereof
JP2016084417A (ja) * 2014-10-27 2016-05-19 紀州技研工業株式会社 インクジェットインク及びその印字方法
JP2019014912A (ja) * 2015-01-21 2019-01-31 クオリカプス株式会社 インク及びこれを用いた可食体の製造方法並びに可食体の印刷方法
JP2021187901A (ja) * 2020-05-27 2021-12-13 紀州技研工業株式会社 錠剤用インクジェットインク
KR102350083B1 (ko) * 2020-07-10 2022-01-10 이상주 레이저 시술용 마커 조성물 및 이를 이용한 레이저 조사방법

Also Published As

Publication number Publication date
TW202348748A (zh) 2023-12-16
JP7833135B2 (ja) 2026-03-19
CN118715294A (zh) 2024-09-27
JPWO2023157954A1 (https=) 2023-08-24

Similar Documents

Publication Publication Date Title
CN104771331B (zh) 一种透明质酸弹性体及其应用
JP6771138B2 (ja) インク及びこれを用いた可食体の製造方法並びに可食体の印刷方法
DE60105812T2 (de) Perlglanztinten, schreibgeräte und verfahren
DE60116076T2 (de) Scherfluidisierende schreibzusammensetzungen, schreibgeräte und verfahren
JP6960695B1 (ja) 錠剤用インクジェットインク
EP3650006A1 (en) Cosmetic ink, inkjet printing ink containing same, ink cartridge, and cosmetic sheet and method for producing same
Granick et al. Surgical skin-marking techniques
JPWO2019039473A1 (ja) ハイドロゲル組成物、生体組織の模型、及び生体組織の模型の製造方法
JP7833135B2 (ja) サージカルマーキング用インク
CN112126279A (zh) 用于手术切口标记的显色墨水、其制备方法及使用该显色墨水的记号笔
JP5037958B2 (ja) 水性ボールペン用インキ組成物
JP7186416B2 (ja) 水系メイクアップ化粧料
JP2021130786A (ja) インク、貼付用キット、貼付用シート、及び貼付用シートを製造する方法
WO2023157953A1 (ja) サージカルインク、同インクの作製方法、及び同インクを用いたサージカルペン
ES3056782T3 (en) Non newtonian ballpoint pen ink comprising cellulose nanofibers
JP7454386B2 (ja) 筆記具用水性インク組成物
JP7136421B2 (ja) インクジェット用インク
WO2024214776A1 (ja) 皮膚マーカー用インキおよび皮膚マーカー
JP5037815B2 (ja) 変色もしくは消色可能なノック式水性ボールペン
KR102815883B1 (ko) 멜라닌 및 철 복합체를 포함하는 타투용 염료조성물 및 이의 제조방법
JP7545680B2 (ja) インクジェット用インク
JP2020139086A (ja) 筆記具用水性インキ組成物、およびそれを用いた筆記具
EP4127083B1 (en) Peelable ink composition for non-porous substrates
CN118284672A (zh) 书写工具用水性墨组合物和书写工具
JP2025139425A (ja) 墨汁様組成物、筆記具、及び筆記具セット

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23756478

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2024501454

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 202380022126.6

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 23756478

Country of ref document: EP

Kind code of ref document: A1